Literature DB >> 8432472

Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.

D G de Silva1, L N Mendis, N Sheron, G J Alexander, D C Candy, H Chart, B Rowe.   

Abstract

Serum interleukin 6 (IL-6) and tumour necrosis factor (TNF) were measured in children with dysentery during an epidemic caused by Shigella dysenteriae 1. IL-6 and TNF were also measured in fresh stool filtrates from children with acute gastroenteritis. The median serum IL-6 concentration was raised significantly in the children with complications (haemolytic uraemic syndrome, leukemoid reaction, thrombocytopenia, thrombocytosis, and severe colitis lasting more than one week) during the first week (n = 18, 9-7728 pg/ml; median 107) and in the second week (n = 13, 5-312 pg/ml; median 77), compared with convalescent sera (n = 10, < 3-85 pg/ml; median 39; p < 0.02 and < 0.05 respectively). The median IL-6 concentration during the first week was significantly higher in the group with complicated disease than in those with no complications (n = 8, < 3-37 pg/ml; median 5; p < 0.001). Although serum TNF concentrations were significantly raised in the complicated group during the first and second weeks of the illness and in the uncomplicated group compared with convalescence, there was no significant difference in the TNF concentrations between the complicated and uncomplicated groups. IL-6 was detectable in stool filtrates from eight of 13 children with S dysenteriae 1 infection and four of eight children with S flexneri infection. It was not detectable in Cryptosporidia, rotavirus, or adenovirus infections, those with pathogen-negative acute diarrhoea or controls. Seven of 13 children with S dysenteriae 1 and three of nine children with S flexneri infections had TNF detectable in stools. None of the children with Salmonella, Cryptosporidia, rotavirus of children with pathogen-negative diarrhoea and controls had detectable TNF in stool filtrates. It is postulated that the local and generalised vasculitis observed in shigellosis may be related to a direct effect of Shiga toxin on endothelial cells or caused by cytokine production stimulated by endotoxin, or both.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432472      PMCID: PMC1373969          DOI: 10.1136/gut.34.2.194

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Monoclonal antibody to TNF in severe septic shock.

Authors:  A R Exley; J Cohen; W Buurman; R Owen; G Hanson; J Lumley; J M Aulakh; M Bodmer; A Riddell; S Stephens
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

2.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.

Authors:  H F Starnes; M K Pearce; A Tewari; J H Yim; J C Zou; J S Abrams
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

3.  Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Authors:  H Chart; H R Smith; S M Scotland; B Rowe; D V Milford; C M Taylor
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

4.  Activation of coagulation after administration of tumor necrosis factor to normal subjects.

Authors:  T van der Poll; H R Büller; H ten Cate; C H Wortel; K A Bauer; S J van Deventer; C E Hack; H P Sauerwein; R D Rosenberg; J W ten Cate
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

5.  Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

6.  Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.

Authors:  S Hedges; P Anderson; G Lidin-Janson; P de Man; C Svanborg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  Increased plasma levels of interleukin-6 in sepsis.

Authors:  C E Hack; E R De Groot; R J Felt-Bersma; J H Nuijens; R J Strack Van Schijndel; A J Eerenberg-Belmer; L G Thijs; L A Aarden
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

9.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Authors:  Y Fong; K J Tracey; L L Moldawer; D G Hesse; K B Manogue; J S Kenney; A T Lee; G C Kuo; A C Allison; S F Lowry
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  25 in total

1.  T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase.

Authors:  Mark W Musch; Lane L Clarke; Daniel Mamah; Lara R Gawenis; Zheng Zhang; William Ellsworth; David Shalowitz; Navdha Mittal; Petros Efthimiou; Ziad Alnadjim; Steve D Hurst; Eugene B Chang; Terrence A Barrett
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers.

Authors:  Zhi-Dong Jiang; David Greenberg; James P Nataro; Robert Steffen; Herbert L DuPont
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Inhibition of TNF-alpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression.

Authors:  B Saud; J Nandi; G Ong; S Finocchiaro; R A Levine
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

4.  Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors:  K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

Authors:  A Ferguson; K A Humphreys; N M Croft
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

6.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 7.  Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.

Authors:  Jan Däbritz; Jason Musci; Dirk Foell
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants.

Authors:  Antonella Cersini; Maria Celeste Martino; Irene Martini; Giacomo Rossi; Maria Lina Bernardini
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Peripheral blood neutrophil responses in children with shigellosis.

Authors:  T Azim; L N Islam; R C Halder; J Hamadani; N Khanum; M S Sarker; M A Salam; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

10.  Cytokines in the stools of children with complicated shigellosis.

Authors:  T Azim; R C Halder; M S Sarker; S Ahmed; J Hamadani; A Chowdhury; F Qadri; M A Salam; R B Sack; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.